Among them, the five key targets with the highest degree values were GAPDH, SRC, HSP90AA1, JUN, and ALB, which play significant roles in the treatment of AD mainly through MAPK, Neurotrophin, Calcium, cAMP, neurodegeneration-multiple diseases, FoxO signaling pathways. This evidence concerns the gene JUN and Alzheimer disease.